Formyl peptide receptor-like 2 is expressed and functional in plasmacytoid dendritic cells, tissue-specific macrophage subpopulations, and eosinophils

Journal of Immunology

Volumn 182, Issue 8, 2009, Pages 4974-4984

  Devosse, Thalie ^a   Guillabert, Aude ^a   D'Haene, Nicky ^a   Berton, Alix ^a   De Nadai, Patricia ^a   Noel, Sophie ^b   Brait, Maryse ^b   Franssen, Jean Denis ^b   Sozzani, Silvano ^c   Salmon, Isabelle ^a   Parmentier, Marc ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b Euroscreen SA   (Belgium)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR 2; FORMYLPEPTIDE RECEPTOR LIKE 2; UNCLASSIFIED DRUG; FORMYL PEPTIDE RECEPTOR 2, MOUSE; FPR3 PROTEIN, HUMAN;

ALLERGY; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL POPULATION; CHEMOTAXIS; COLON; CONTROLLED STUDY; DENDRITIC CELL; EOSINOPHIL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOCYTE; LUNG; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN; TISSUE MICROARRAY; TISSUE SPECIFICITY; ANIMAL; ANTIBODY SPECIFICITY; CELL CULTURE; CELL MOTION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; DENDRITIC CELLS; EOSINOPHILS; GENE EXPRESSION REGULATION; HUMANS; MACROPHAGES; MICE; ORGAN SPECIFICITY; RECEPTORS, FORMYL PEPTIDE; TISSUE ARRAY ANALYSIS;

EID: 65249087496     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803128     Document Type: Article

References (63)

1. Showell, H. J., R. J. Freer, S. H. Zigmond, E. Schiffmann, S. Aswanikumar, B. Corcoran, and E. L. Becker. 1976. The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils. J. Exp. Med. 143: 1154-1169.
2. Boulay, F., M. Tardif, L. Brouchon, and P. Vignais. 1990. The human N-formylpeptide receptor: characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors. Biochemistry 29: 11123-11133.
3. Boulay, F., M. Tardif, L. Brouchon, and P. Vignais. 1990. Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA. Biochem. Biophys. Res. Commun. 168: 1103-1109. (Pubitemid 20175994)
4. Ye, R. D., S. L. Cavanagh, O. Quehenberger, E. R. Prossnitz, and C. G. Cochrane. 1992. Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor. Biochem. Biophys. Res. Commun. 184: 582-589.
5. Murphy, P. M., T. Ozcelik, R. T. Kenney, H. L. Tiffany, D. McDermott, and U. Francke. 1992. A structural homologue of the N-formyl peptide receptor. Characterization and chromosome mapping of a peptide chemoattractant receptor family. J. Biol. Chem. 267: 7637-7643.
6. Bao, L., N. P. Gerard, R. L. Eddy, Jr., T. B. Shows, and C. Gerard. 1992. Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19. Genomics 13: 437-440.
7. Schiffmann, E., B. A. Corcoran, and S. M. Wahl. 1975. N-Formylmethionyl peptides as chemoattractants for leucocytes. Proc. Natl. Acad. Sci. USA 72: 1059-1062.
8. Schiffmann, E., H. V. Showell, B. A. Corcoran, P. A. Ward, E. Smith, and E. L. Becker. 1975. The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli. J. Immunol. 114: 1831-1837.
9. Marasco, W. A., S. H. Phan, H. Krutzsch, H. J. Showell, D. E. Feltner, R. Nairn, E. L. Becker, and P. A. Ward. 1984. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J. Biol. Chem. 259: 5430-5439.
10. Carp, H. 1982. Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J. Exp. Med. 155: 264-275. (Pubitemid 12209828)
11. Durstin, M., J. L. Gao, H. L. Tiffany, D. McDermott, and P. M. Murphy. 1994. Differential expression of members of the N-formylpeptide receptor gene-cluster in human phagocytes. Biochem. Biophys. Res. Commun. 201: 174-179. (Pubitemid 24213710)
12. Yang, D., Q. Chen, Y. Le, J. M. Wang, and J. J. Oppenheim. 2001. Differential regulation of formyl peptide receptor-like 1 expression during the differentiation of monocytes to dendritic cells and macrophages. J. Immunol. 166: 4092-4098. (Pubitemid 32224940)
13. Yang, D., Q. Chen, B. Gertz, R. He, M. Phulsuksombati, R. D. Ye, and J. J. Oppenheim. 2002. Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation. J. Leukocyte Biol. 72: 598-607.
14. Migeotte, I., D. Communi, and M. Parmentier. 2006. Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. Cytokine Growth Factor Rev. 17: 501-519. (Pubitemid 44793122)
15. Harada, M., Y. Habata, M. Hosoya, K. Nishi, R. Fujii, M. Kobayashi, and S. Hinuma. 2004. N-Formylated humanin activates both formyl peptide receptor-like 1 and 2. Biochem. Biophys. Res. Commun. 324: 255-261. (Pubitemid 39311487)
16. Ying, G., P. Iribarren, Y. Zhou, W. Gong, N. Zhang, Z. X. Yu, Y. Le, Y. Cui, and J. M. Wang. 2004. Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor. J. Immunol. 172: 7078-7085. (Pubitemid 38669150)
17. Migeotte, I., E. Riboldi, J. D. Franssen, F. Gregoire, C. Loison, V. Wittamer, M. Detheux, P. Robberecht, S. Costagliola, G. Vassart, et al. 2005. Identification and characterization of an endogenous chemotactic ligand specific for FPRL2. J. Exp. Med. 201: 83-93. (Pubitemid 40130086)
18. Kang, H. K., H. Y. Lee, M. K. Kim, K. S. Park, Y. M. Park, J. Y. Kwak, and Y. S. Bae. 2005. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met inhibits human monocyte-derived dendritic cell maturation via formyl peptide receptor and formyl peptide receptor-like 2. J. Immunol. 175: 685-692.
19. Gao, J. L., H. Chen, J. D. Filie, C. A. Kozak, and P. M. Murphy. 1998. Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse. Genomics 51: 270-276. (Pubitemid 28395033)
20. Gao, J. L., and P. M. Murphy. 1993. Species and subtype variants of the N-formyl peptide chemotactic receptor reveal multiple important functional domains. J. Biol. Chem. 268: 25395-25401.
21. Takano, T., S. Fiore, J. F. Maddox, H. R. Brady, N. A. Petasis, and C. N. Serhan. 1997. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J. Exp. Med. 185: 1693-1704. (Pubitemid 27203265)
22. Hartt, J. K., G. Barish, P. M. Murphy, and J. L. Gao. 1999. N-formylpeptides induce two distinct concentration optima for mouse neutrophil chemotaxis by differential interaction with two N-formylpeptide receptor (FPR) subtypes. Molecular characterization of FPR2, a second mouse neutrophil FPR. J. Exp. Med. 190: 741-747.
23. Cui, Y., Y. Le, H. Yazawa, W. Gong, and J. M. Wang. 2002. Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease. J. Leukocyte Biol. 72: 628-635. (Pubitemid 36277832)
24. Le, Y., P. M. Murphy, and J. M. Wang. 2002. Formyl-peptide receptors revisited. Trends Immunol. 23: 541-548.
25. Gao, J. L., A. Guillabert, J. Hu, Y. Le, E. Urizar, E. Seligman, K. J. Fang, X. Yuan, V. Imbault, D. Communi, et al. 2007. F2L, a peptide derived from heme-binding protein, chemoattracts mouse neutrophils by specifically activating Fpr2, the low-affinity N-formylpeptide receptor. J. Immunol. 178: 1450-1456.
26. Vermi, W., E. Riboldi, V. Wittamer, F. Gentili, W. Luini, S. Marrelli, A. Vecchi, J. D. Franssen, D. Communi, L. Massardi, et al. Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J. Exp. Med. 201: 509-515.
27. Zigmond, S. H., and J. G. Hirsch. 1973. Leukocyte locomotion and chemotaxis: new methods for evaluation, and demonstration of a cell-derived chemotactic factor. J. Exp. Med. 137: 387-410.
28. Boyden, S. 1962. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J. Exp. Med. 115: 453-466.
29. Woerly, G., S. Loiseau, M. Loyens, C. Schoch, and M. Capron. 2003. Inhibitory effects of ketotifen on eotaxin-dependent activation of eosinophils: consequences for allergic eye diseases. Allergy 58: 397-406. (Pubitemid 36605728)
30. Mantovani, A., A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25: 677-686. (Pubitemid 39457982)
31. Indrasingh, I., Koshy, S., and Vettivel, S. 2003. Morphology and distribution of human colonic dendritic cells: A light microscopic zinc iodide-osmium study. J. Anat. Soc. India 52: 7-11. (Pubitemid 36935068)
32. Svensson, L., E. Redvall, C. Bjorn, J. Karlsson, A. M. Bergin, M. J. Rabiet, C. Dahlgren, and C. Wenneras. 2007. House dust mite allergen activates human eosinophils via formyl peptide receptor and formyl peptide receptor-like 1. Eur.J. Immunol. 37: 1966-1977. (Pubitemid 47065132)
33. Hume, D. A. 2006. The mononuclear phagocyte system. Curr. Opin. Immunol. 18: 49-53.
34. Gordon, S., S. Keshav, and L. P. Chung. 1988. Mononuclear phagocytes: tissue distribution and functional heterogeneity. Curr. Opin. Immunol. 1: 26-35. (Pubitemid 19112299)
35. Mellman, I., and R. M. Steinman. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell 106: 255-258. (Pubitemid 32772607)
36. Rogler, G., M. Hausmann, D. Vogl, E. Aschenbrenner, T. Andus, W. Falk, R. Andreesen, J. Scholmerich, and V. Gross. 1998. Isolation and phenotypic characterization of colonic macrophages. Clin. Exp. Immunol. 112: 205-215. (Pubitemid 28266678)
37. Smythies, L. E., M. Sellers, R. H. Clements, M. Mosteller-Barnum, G. Meng, W. H. Benjamin, J. M. Orenstein, and P. D. Smith. 2005. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J. Clin. Invest. 115: 66-75.
38. Schenk, M., and C. Mueller. 2007. Adaptations of intestinal macrophages to an antigen-rich environment. Semin. Immunol. 19: 84-93. (Pubitemid 46810284)
39. Prieditis, H., and I. Y. Adamson. 1996. Alveolar macrophage kinetics and multinucleated giant cell formation after lung injury. J. Leukocyte Biol. 59: 534-538. (Pubitemid 26155297)
40. Chambers, T. J. 1978. Multinucleate giant cells. J. Pathol. 126: 125-148.
41. Helming, L., and S. Gordon. 2007. The molecular basis of macrophage fusion. Immunobiology 212: 785-793.
42. Mosser, D. M. 2003. The many faces of macrophage activation. J. Leukocyte Biol. 73: 209-212.
43. Duffield, J. S. 2003. The inflammatory macrophage: a story of Jekyll and Hyde. Clin. Sci. 104: 27-38.
44. Martinez, F. O., S. Gordon, M. Locati, and A. Mantovani. 2006. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177: 7303-7311.
45. Ghassabeh, G. H., P. De Baetselier, L. Brys, W. Noel, J. A. Van Ginderachter, S. Meerschaut, A. Beschin, F. Brombacher, and G. Raes. 2006. Identification of a common gene signature for type H cytokine-associated myeloid cells elicited in vivo in different pathologic conditions. Blood 108: 575-583.
46. Nair, M. G., K. J. Guild, and D. Artis. 2006. Novel effector molecules in type 2 inflammation: lessons drawn from helminth infection and allergy. J. Immunol. 177: 1393-1399.
47. Mantovani, A., P. Allavena, and A. Sica. 2004. Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression. Eur. J. Cancer 40: 1660-1667. (Pubitemid 38902900)
48. Klimp, A. H., E. G. E. de Vries, G. L. Scherphof, and T. Daemen. 2002. A potential role of macrophage activation in the treatment of cancer. Crit. Rev. Oncol. Hematol. 44: 143-161. (Pubitemid 36159043)
49. Kadowaki, N., S. Ho, S. Antonenko, R. D. Malefyt, R. A. Kastelein, F. Bazan, and Y. J. Liu. 2001. Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194: 863-869. (Pubitemid 32983021)
50. Colonna, M., A. Krug, and M. Cella. 2002. Interferon-producing cells: on the front line in immune responses against pathogens. Curr. Opin. Immunol. 14: 373-379. (Pubitemid 34327981)
51. Cella, M., D. Jarrossay, F. Facchetti, O. Alebardi, H. Nakajima, A. Lanzavecchia, and M. Colonna. 2000. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce high levels of type IIFN. J. Invest. Dermatol. 114: 224. (Pubitemid 29372419)
52. Soumelis, V., I. Scott, F. Gheyas, D. Bouhour, G. Cozon, L. Cotte, L. Huang, J. A. Levy, and Y. J. Liu. 2001. Depletion of circulating natural type I interferon-producing cells in HIV-infected AIDS patients. Blood 98: 906-912.
53. Kanto, T., M. Inoue, H. Miyatake, A. Sato, M. Sakakibara, T. Yakushijin, C. Oki, I. Itose, N. Hiramatsu, T. Takehara, A. Kasahara, and N. Hayashi. 2004. Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J. Infect. Dis. 190: 1919-1926. (Pubitemid 39564696)
54. Bilsborough, J., and J. L. Viney. 2002. Getting to the guts of immune regulation. Immunology 106: 139-143.
55. + regulatory T cells. J. Immunol. 173: 4433-4442.
56. Farkas, L., K. Beiske, F. Lund-Johansen, P. Brandtzaeg, and F. L. Jahnsen. 2001. Plasmacytoid dendritic cells (natural interferon-alpha/beta- producing cells) accumulate in cutaneous lupus erythematosus lesions. Am. J. Pathol. 159: 237-243. (Pubitemid 33704208)
57. Sozzani, S. 2005. Dendritic cell trafficking: more than just chemokines. Cytokine Growth Factor Rev. 16: 581-592. (Pubitemid 41505518)
58. Svensson, L., C. Dahlgren, and C. Wenneras. 2002. The chemoattractant Trp-Lys-Tyr-Met-Val-D-Met activates eosinophils through the formyl peptide receptor and one of its homologues, formyl peptide receptor-like 1. J. Leukocyte Biol. 72: 810-818. (Pubitemid 36277853)
59. Rothenberg, M. E., and S. P. Hogan. 2006. The eosinophil. Annu. Rev. Immunol. 24: 147-174.
60. Hidi, R., E. Coeffier, and B. B. Vargaftig. 1992. Formation of Ltb4 by Fmlp-stimulated alveolar macrophages accounts for eosinophil migration in vitro. J. Leukocyte Biol. 51: 425-431.
61. Royer, J. F., P. Schratl, S. Lorenz, E. Kostenis, T. Ulven, R. Schuligoi, B. A. Peskar, and A. Heinemann. 2007. A novel antagonist of CRTH2 blocks eosinophil release from bone marrow, chemotaxis and respiratory burst. Allergy 62: 1401-1409.
62. Svensson, L., E. Redvall, C. Bjorn, J. Karlsson, A. M. Bergin, M. J. Rabiet, C. Dahgren, and C. Wenneras. 2007. House dust mite allergen activates human eosinophils via formyl peptide receptor and formyl peptide receptor-like 1. Eur. J. Immunol. 37: 1966-1977. (Pubitemid 47065132)
63. Taketani, S., Y. Adachi, H. Kohno, S. Ikehara, R. Tokunaga, and T. Ishii. 1998. Molecular characterization of a newly identified heme-binding protein induced during differentiation of urine erythroleukemia cells. J. Biol. Chem. 273: 31388-31394. (Pubitemid 28533157)